Trial Profile
The use of a long-acting sub-cutaneous insulin analogue in the management of hyperglycaemic emergencies
Status:
Withdrawn prior to enrolment
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 15 May 2007
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary)
- Indications Diabetic ketoacidosis; Hyperglycaemic hyperosmolar nonketotic coma
- Focus Therapeutic Use
- 15 May 2007 New trial record.